These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31543257)

  • 1. Correlation among automated scores of agglutination, antigen density by flow cytometry and genetics of D variants.
    Arnoni CP; Muniz JG; Vendrame TAP; Medeiros R; Cortez AJP; Latini FRM; Castilho L
    Transfus Apher Sci; 2019 Oct; 58(5):680-684. PubMed ID: 31543257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of
    Hudgins JP; Matsushita C; Tuma CW; O'Brien L; Shulman IA
    Immunohematology; 2021; 37(4):165-170. PubMed ID: 34964318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
    Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.
    El Housse H; El Wafi M; Ouabdelmoumene Z; Zarati F; Alid R; Nourichafi N; Bouisk K; Benajiba M; Férec C; Fichou Y; Habti N
    Blood Transfus; 2019 Mar; 17(2):151-156. PubMed ID: 30418133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of RhD agglutination for the detection of weak D red cells by anti-D flow cytometry.
    Grey DE; Davies JI; Connolly M; Fong EA; Erber WN
    Clin Lab Haematol; 2005 Apr; 27(2):127-33. PubMed ID: 15784128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant RHD Types in Brazilians With Discrepancies in RhD Typing.
    Campos FC; Mota MA; Aravechia MG; Torres KB; Bub CB; Kutner JM; Castilho L
    J Clin Lab Anal; 2016 Nov; 30(6):845-848. PubMed ID: 27076392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.
    Sandler SG; Chen LN; Flegel WA
    Br J Haematol; 2017 Oct; 179(1):10-19. PubMed ID: 28508413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of weak D antigen by flow cytometry].
    Wu XY; Xu HX; Xiong W; Shao CP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):474-7. PubMed ID: 23628057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
    Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
    Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHD variants in Flanders, Belgium.
    Van Sandt VS; Gassner C; Emonds MP; Legler TJ; Mahieu S; Körmöczi GF
    Transfusion; 2015 Jun; 55(6 Pt 2):1411-7. PubMed ID: 25413499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RHD genotyping to resolve weak and discrepant RhD patient phenotypes.
    Barriteau CM; Lindholm PF; Hartman K; Sumugod RD; Ramsey G
    Transfusion; 2022 Nov; 62(11):2194-2199. PubMed ID: 36218305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.
    Lukacevic Krstic J; Dajak S; Bingulac-Popovic J; Dogic V; Mratinovic-Mikulandra J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28649781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterisation of RhD variants in North Indian blood donor population.
    Khetan D; Verma A; Chaudhary RK; Shukla JS
    Transfus Med; 2020 Aug; 30(4):295-303. PubMed ID: 32488899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
    Credidio DC; Pellegrino J; Castilho L
    Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene.
    Beckers EA; Faas BH; Ligthart P; Overbeeke MA; von dem Borne AE; van der Schoot CE; van Rhenen DJ
    Transfusion; 1997 Jun; 37(6):616-23. PubMed ID: 9191822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of RhD variant phenotypes among blood donors: A study from the coastal region of India.
    Polavarapu I; Mishra G; Shastry S; Kulkarni S
    Transfus Apher Sci; 2021 Aug; 60(4):103142. PubMed ID: 33962886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do we identify RHD variants using a practical molecular approach?
    Arnoni CP; Latini FR; Muniz JG; Gazito D; Person Rde M; de Paula Vendrame TA; Barreto JA; Castilho L
    Transfusion; 2014 Apr; 54(4):962-9. PubMed ID: 24579654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of RHD alleles present in serologically RHD-negative donors determined by a sensitive microplate technique.
    de Paula Vendrame TA; Prisco Arnoni C; Guilhem Muniz J; de Medeiros Person R; Pereira Cortez AJ; Roche Moreira Latini F; Castilho L
    Vox Sang; 2019 Nov; 114(8):869-875. PubMed ID: 31587310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population.
    Kulkarni S; Kasiviswanathan V; Ghosh K
    Blood Transfus; 2013 Jan; 11(1):37-42. PubMed ID: 22871818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.